SN.L Smith & Nephew plc
Company Analysis
Latest News
Smith & Nephew Shares Jump 7.7% on Faster Growth, but Can Momentum Survive a Guidance Cut?
Shares of Smith & Nephew surged to £1,190 on November 5, their best single-day move in months, after the medical-device maker reported accelerating quarterly...
🟢 Smith & Nephew is trading 6.49% up today as Q3 revenue growth accelerated
Smith & Nephew is trading at £1,190.00, up 6.49%, after quarterly revenue growth accelerated. - The November 4 update reported Q3 revenue growth of 3.4%, up...
🟢 Smith & Nephew is trading 5% up today amid faster Q3 revenue growth
Smith & Nephew is trading at £1,171.00 (+5.19%), amid faster Q3 revenue growth. - Q3 revenue growth accelerated to 3.4% from 1.6% in Q2; Sports Medicine & ENT...
🟢 Smith & Nephew is trading 4.18% up
Smith & Nephew is trading at £1134.00, up 4.18%. Healthcare rose 1.35%, offering a possible sector tailwind, but no clear company-specific catalyst was...
🟢 Smith & Nephew is trading 4.07% up today
Smith & Nephew is trading at £1049.50, up 4.07%, with no confirmed company-specific announcement directly explaining the rise. - Completed a $700 million...
🔴 Smith & Nephew is trading 4.04% down today as healthcare stocks fall amid insurance concerns
Smith & Nephew is trading at £1021.00 (-4.04%) as healthcare stocks fall broadly. - The XLV healthcare ETF is down 2.19% amid worsening insurance-coverage...
🔴 Smith & Nephew is trading 4.14% down today after CFO John Rogers announces September 2026 departure
Smith & Nephew is trading at £1064.50 (-4.14%) after CFO John Rogers announced he will leave on September 30, 2026, for an external U.S. role. • Investors may...
Smith & Nephew Stake Hits 14.2% as Cevian Capital Increases Pressure
Cevian Capital II GP Limited increased its total voting rights in medical technology firm Smith & Nephew plc to 14.21%. This represents a rise from the 14.01%...
Smith & Nephew Slashes Its Sales Outlook by a Third — Can Cost-Cutting Alone Restore Investor Confidence?
Shares in Smith & Nephew slid 3.2% to £1,122 on August 7, extending a week-long selloff that has erased more than 6% since the medical-device maker disclosed...
Smith & Nephew Slashes Its Sales Outlook by a Third — Can Cost-Cutting Alone Restore Investor Confidence?
Shares in Smith & Nephew slid 3.2% to £1,122 on August 7, extending a week-long selloff that has erased more than 6% since the medical-device maker disclosed...
🔴 Smith & Nephew is trading 6.3% down today after cutting full-year revenue guidance
Smith & Nephew is trading 6.3% down today at £1122.00 after the company lowered its full-year revenue guidance despite maintaining its profit and cash-flow...
🔴 Smith & Nephew is trading 6.9% down today, reversing gains from the previous session's sentiment-driven rebound
Smith & Nephew is trading 6.9% down at £1114.00, reversing gains from a sentiment-driven rebound in the previous session. • The stock climbed 4.7% on August...
🟢 Smith & Nephew is trading 4.7% up today amid a broad risk-on market tone
Smith & Nephew is trading at £1207.50 (+4.66%) amid a broad risk-on market tone rather than a clear company-specific event. • U.S. equity markets are trending...